End Cash: The amount of cash held by the company for the given period.
Pyxis Oncology, Inc. (PYXS) had End Cash of $10.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-22.00M |
|
-- |
|
-- |
|
$23.46M |
|
$-23.46M |
|
$1.46M |
|
$-22.00M |
|
$-22.00M |
|
$-22.00M |
|
$-22.00M |
|
$-22.00M |
|
$-22.00M |
|
$-23.46M |
|
$-23.47M |
|
62.56M |
|
62.56M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$83.07M |
|
$8.46M |
|
$22.53M |
|
$105.60M |
|
$19.38M |
|
-- |
|
$17.44M |
|
$36.83M |
|
$68.78M |
|
$66.34M |
|
$68.78M |
|
62.15M |
|
| Cash Flow Statement Financials | |
$-53.08M |
|
$42.60M |
|
$-0.07M |
|
$20.95M |
|
|
End Cash |
$10.39M |
$-10.55M |
|
$9.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-53.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.99% |
|
-33.16% |
|
-20.84% |
|
-31.99% |
|
$1.11 |
|
$-0.85 |
|
$-0.85 |
|